You are here: Industry Insights > Heart

News List

Cheaper drug just as effective protecting heart in Duchenne muscular dystrophy worldpharmanews
September 27, 2019
A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with ...
Dapagliflozin Lowers Risk for Worsening Heart Failure drugs
September 24, 2019
For patients with heart failure and reduced ejection fraction, dapagliflozin is associated with a lower risk for worsening heart failure or death from cardiovascular causes, regardless of the presence of type 2 diabetes ...
SGLT2 Inhibitors Linked to Lower Risk for Heart Failure drugs
September 23, 2019
Use of sodium glucose cotransporter 2 (SGLT2) inhibitors for type 2 diabetes is associated with a reduced risk for heart failure ...
These Diets Helped Women With Diabetes Cut Heart Attack, Stroke Risk drugs
September 20, 2019
Eating patterns similar to the Mediterranean diet and the blood pressure-lowering DASH may help older women with Type 2 diabetes ward off heart attacks, strokes and related problems, new research suggests.
Scientists Discover New Way Fat Harms Your Arteries drugs
September 20, 2019
Scientists may have found a way that obesity directly damages the arteries and contributes to heart disease -- a discovery that they say could eventually lead to new treatments ...
Opioid Epidemic Tied to Doubling of Dangerous Heart Infections drugs
September 19, 2019
Addiction and overdose deaths aren't the only consequence of America's opioid epidemic. Cases of a potentially deadly heart infection have risen alarmingly, too.
All-in-One Pill Helps Protect Heart drugs
September 19, 2019
Researchers tested a combo pill containing low doses of two blood pressure medications, a statin and a medication that keeps you from retaining excess fluid.
FDA grants Fast Track designation for Farxiga in heart failure worldpharmanews
September 18, 2019
AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the risk of cardiovascular (CV) death...
Fast Track designation given to heart failure treatment europeanpharmaceuticalreview
September 18, 2019
Farxiga (dapagliflozin) has been given Fast Track designation by the FDA to reduce the risk of cardiovascular death.
Vitamin D Is Good for the Bones, But What About the Heart? drugs
September 18, 2019
Vitamin D plays an important role in overall health, but if you've been taking supplements to strengthen your heart, recent research may disappoint you.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page